Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norbert Vey

Showing results (21-30 of 251) with videos related to

Pageof 26
Sort By:
Anti-Cancer Agents in Medicinal Chemistry|January 24, 2012
Design of N-substituted amino caproic hydroxamic acid histone deacetylase inhibitors reveal an essential role for cap atomic compositionJean M Brunel, Chanaz Salmi-Smail, Audrey Restouin, et al.
British Journal of Haematology|October 3, 2002
Low blood dendritic cells in chronic myeloid leukaemia patients correlates with loss of CD34+/CD38- primitive haematopoietic progenitorsMohamad Mohty, Daniel Isnardon, Norbert Vey, et al.
Bulletin Du Cancer|November 12, 2003
[Immunotherapy of acute myeloid leukemias: development of vaccines and cell therapy approaches]Mohamad Mohty, Béatrice Gaugler, Boris Calmels, et al.
International Journal of Cancer|July 20, 2020
Risk of secondary hematologic malignancies associated with breast cancer chemotherapy and G-CSF support: A nationwide population-based cohortMarie Joelle Jabagi, Norbert Vey, Anthony Goncalves, et al.
Medecine Sciences : M/S|April 13, 2012
[Perception by cancer patients of biomedical research in the era of large-scale biobanking]Julien Mancini, Christian Chabannon, Norbert Vey, et al.
JAMA Network Open|January 19, 2019
Evaluation of the Incidence of Hematologic Malignant Neoplasms Among Breast Cancer Survivors in FranceMarie Joelle Jabagi, Norbert Vey, Anthony Goncalves, et al.
Cancers|October 2, 2019
Risk of Hematologic Malignant Neoplasms after Postoperative Treatment of Breast CancerMarie Joelle Jabagi, Anthony Goncalves, Norbert Vey, et al.
Blood Transfusion = Trasfusione Del Sangue|February 16, 2023
Therapeutic efficacy of platelet transfusion treated with amotosalen/UVA pathogen inactivation technology (INTERCEPT<sup>TM</sup> Blood System) in acute myeloid leukemia patients undergoing chemotherapy with curative intent: a single center experiencePatrick Ladaique, Jean-Michel Etienne, Pascal Pedini, et al.
Leukemia Research|August 22, 2015
Updated recommendations on the management of gastrointestinal disturbances during iron chelation therapy with Deferasirox in transfusion dependent patients with myelodysplastic syndrome - Emphasis on optimized dosing schedules and new formulationsFlorian Nolte, Emanuele Angelucci, Massimo Breccia, et al.
Journal of the National Cancer Institute|December 22, 2010
Consent for biobanking: assessing the understanding and views of cancer patientsJulien Mancini, Isabelle Pellegrini, Frédéric Viret, et al.
Pageof 26

Showing results (21-30 of 251) with videos related to

Sort By:
Pageof 26
Anti-Cancer Agents in Medicinal Chemistry|January 24, 2012
Design of N-substituted amino caproic hydroxamic acid histone deacetylase inhibitors reveal an essential role for cap atomic compositionJean M Brunel, Chanaz Salmi-Smail, Audrey Restouin, et al.
British Journal of Haematology|October 3, 2002
Low blood dendritic cells in chronic myeloid leukaemia patients correlates with loss of CD34+/CD38- primitive haematopoietic progenitorsMohamad Mohty, Daniel Isnardon, Norbert Vey, et al.
Bulletin Du Cancer|November 12, 2003
[Immunotherapy of acute myeloid leukemias: development of vaccines and cell therapy approaches]Mohamad Mohty, Béatrice Gaugler, Boris Calmels, et al.
International Journal of Cancer|July 20, 2020
Risk of secondary hematologic malignancies associated with breast cancer chemotherapy and G-CSF support: A nationwide population-based cohortMarie Joelle Jabagi, Norbert Vey, Anthony Goncalves, et al.
Medecine Sciences : M/S|April 13, 2012
[Perception by cancer patients of biomedical research in the era of large-scale biobanking]Julien Mancini, Christian Chabannon, Norbert Vey, et al.
JAMA Network Open|January 19, 2019
Evaluation of the Incidence of Hematologic Malignant Neoplasms Among Breast Cancer Survivors in FranceMarie Joelle Jabagi, Norbert Vey, Anthony Goncalves, et al.
Cancers|October 2, 2019
Risk of Hematologic Malignant Neoplasms after Postoperative Treatment of Breast CancerMarie Joelle Jabagi, Anthony Goncalves, Norbert Vey, et al.
Blood Transfusion = Trasfusione Del Sangue|February 16, 2023
Therapeutic efficacy of platelet transfusion treated with amotosalen/UVA pathogen inactivation technology (INTERCEPT<sup>TM</sup> Blood System) in acute myeloid leukemia patients undergoing chemotherapy with curative intent: a single center experiencePatrick Ladaique, Jean-Michel Etienne, Pascal Pedini, et al.
Leukemia Research|August 22, 2015
Updated recommendations on the management of gastrointestinal disturbances during iron chelation therapy with Deferasirox in transfusion dependent patients with myelodysplastic syndrome - Emphasis on optimized dosing schedules and new formulationsFlorian Nolte, Emanuele Angelucci, Massimo Breccia, et al.
Journal of the National Cancer Institute|December 22, 2010
Consent for biobanking: assessing the understanding and views of cancer patientsJulien Mancini, Isabelle Pellegrini, Frédéric Viret, et al.
Pageof 26